| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |